Electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation (AF)

Trial Profile

Electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation (AF)

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2012

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Paroxysmal atrial fibrillation
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 01 Nov 2007 Status changed from in progress to completed.
    • 25 Jul 2007 Status changed from recruiting to in progress
    • 03 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top